Cassava Sciences, Alzheimer
Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.
Boston researchers say they’ve created a promising AI model that predicts the likelihood of someone developing Alzheimer’s ...
Breakthrough is going to help treatment and drug trials, scientists say Charles Marshall thinks he can now predict who will get dementia up to nine years before their symptoms appear, with a ...
In a promising study for Alzheimer's disease, scientists in Japan say they have reversed the signs of this debilitating ...
Journal Editorial Report: The week's best and worst from Bill McGurn, Allysia Finley, Mene Ukueberuwa and Dan Henninger. Image: Cristobal Herrera-Ulashkevich ...
A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers Monday, setting the stage for the treatment's expected approval for people with mild dementia caused ...
Researchers have discovered a rare genetic trait that could delay the onset of Alzheimer's in people who face an overwhelming risk of developing the mind-robbing disease. A study published ...
An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration (FDA) advisory panel on Monday. Donanemab is designed to treat symptoms of early Alzheimer’s ...
Federal health advisers have endorsed a closely watched Alzheimer’s drug from Eli Lilly for people with mild dementia WASHINGTON -- A closely watched Alzheimer's drug from Eli Lilly won the ...
Hoau-Yan Wang, a 67-year-old tenured medical professor, was indicted this week for an alleged scheme involving fraudulent ...